Skip to main content
. Author manuscript; available in PMC: 2017 Oct 28.
Published in final edited form as: J Control Release. 2015 Nov 18;240:135–141. doi: 10.1016/j.jconrel.2015.11.019

Table 3.

Advantages of microneedle patches for vaccination in developing countries

Increased vaccine effectiveness
Reduced need for trained healthcare providers
Simplified supply chain
Reduced risk of sharps
Reduced vaccine wastage
No need for vaccine reconstitution
Reduced cost of vaccine/vaccination